Cynosure Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$539K Buy
+2,204
New +$513K 0.07% 78
2024
Q1
Sell
-1,580
Closed -$248K 332
2023
Q4
$248K Buy
+1,580
New +$242K 0.04% 138
2020
Q2
Sell
-3,313
Closed -$434K 38
2020
Q1
$434K Sell
3,313
-585
-15% -$83K 0.31% 36
2019
Q4
$569K Hold
3,898
0.3% 29
2019
Q3
$504K Sell
3,898
-1,379
-26% -$182K 0.27% 31
2019
Q2
$735K Buy
+5,277
New +$730K 0.34% 30

Other funds holding JNJ

Cynosure Group's JNJ Position: Q1 2026 in Review

Cynosure Group opened a new position in Johnson & Johnson (JNJ) in Q1 2026: 2,204 shares worth $539K. The stake represents 0.07% of the portfolio and ranks #78 among its holdings. This is a return to the name: Cynosure Group previously reported a position in JNJ as recently as Q4 2023.

Cynosure Group first reported a position in JNJ in Q2 2019 and has held it in 6 quarters since. The position peaked at $735K in Q2 2019. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Cynosure Group held 2,204 shares of Johnson & Johnson worth $539K as of Q1 2026.
  • Johnson & Johnson was a new Cynosure Group position in Q1 2026.
  • Johnson & Johnson made up 0.07% of Cynosure Group's portfolio in Q1 2026, its #78 holding.
  • Cynosure Group first reported a position in Johnson & Johnson in Q2 2019 and has held it in 6 quarters since.
  • Cynosure Group's Johnson & Johnson position peaked at $735K in Q2 2019.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Cynosure Group's 13F filing for Q1 2026, filed 14 May 2026.